Dosentrx Ltd.

Pharmaceuticals · MODIIN MACCABIM REUT, L3

PharmaceuticalsSEC Form D

Dosentrx Ltd. filed a Form D with the U.S. Securities and Exchange Commission on March 19, 2026, reporting $1,780,000 raised toward a $6,000,000 offering.

Incorporated in Israel and based in MODIIN MACCABIM REUT, L3, it operates in the Pharmaceuticals sector.

Companies file a Form D within 15 days of the first sale of securities in a private offering under Regulation D — an early, public signal that Dosentrx Ltd. has raised capital from private investors.

Browse more recently funded companies in Pharmaceuticals.

Executives & Directors

  • Mark SummersExecutive Officer
  • Jon RobertsDirector
  • Daniel BeckDirector
  • Gerald LiebermanDirector
  • Alan PazExecutive Officer · Director
  • Frank SheehyDirector
  • Liron Levi-GabayExecutive Officer

Recently funded in Pharmaceuticals

Other companies that recently filed a Form D

$50.0KRaised

Matthias Therapeutics, LLC

PharmaceuticalsBASKING RIDGE, NJ
May 14, 2026View SEC Form D
$5.3MRaised

GridAI Technologies Corp.

PharmaceuticalsBOCA RATON, FL
May 11, 2026View SEC Form D
$2.5MRaised

GridAI Technologies Corp.

PharmaceuticalsBOCA RATON, FL
May 8, 2026View SEC Form D
$22.5MRaised

CNS Pharmaceuticals, Inc.

PharmaceuticalsHOUSTON, TX
May 4, 2026View SEC Form D
$4.9MRaised

California Compounding Company, Inc.

PharmaceuticalsLOS ANGELES, CA
May 1, 2026View SEC Form D
Dosentrx Ltd. raised $1.8M — SEC Form D